305 related articles for article (PubMed ID: 17519389)
1. Pathobiology of ALK+ anaplastic large-cell lymphoma.
Amin HM; Lai R
Blood; 2007 Oct; 110(7):2259-67. PubMed ID: 17519389
[TBL] [Abstract][Full Text] [Related]
2. Recombinant expression, characterization, and quantification in human cancer cell lines of the Anaplastic Large-Cell Lymphoma-characteristic NPM-ALK fusion protein.
Kourentzi K; Crum M; Patil U; Prebisch A; Chavan D; Vu B; Zeng Z; Litvinov D; Zu Y; Willson RC
Sci Rep; 2020 Mar; 10(1):5078. PubMed ID: 32193476
[TBL] [Abstract][Full Text] [Related]
3. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
[TBL] [Abstract][Full Text] [Related]
4. EBP2, a novel NPM-ALK-interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53.
Uchihara Y; Tago K; Tamura H; Funakoshi-Tago M
Mol Oncol; 2021 Jan; 15(1):167-194. PubMed ID: 33040459
[TBL] [Abstract][Full Text] [Related]
5. Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.
Song Z; Wu W; Wei W; Xiao W; Lei M; Cai KQ; Huang DW; Jeong S; Zhang JP; Wang H; Kadin ME; Waldmann TA; Staudt LM; Nakagawa M; Yang Y
Blood; 2023 Oct; 142(15):1297-1311. PubMed ID: 37339580
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line.
Sungwan P; Panaampon J; Kariya R; Kamio S; Nakagawa R; Hirozane T; Ogura Y; Abe M; Hirabayashi K; Fujiwara Y; Kikuta K; Okada S
Hum Cell; 2024 May; ():. PubMed ID: 38755432
[TBL] [Abstract][Full Text] [Related]
7. NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma.
Haque M; Li J; Huang YH; Almowaled M; Barger CJ; Karpf AR; Wang P; Chen W; Turner SD; Lai R
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31390744
[TBL] [Abstract][Full Text] [Related]
8. Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function.
Zhang Q; Basappa J; Wang HY; Nunez-Cruz S; Lobello C; Wang S; Liu X; Chekol S; Guo L; Ziober A; Nejati R; Shestov A; Feldman M; Glickson JD; Turner SD; Blair IA; Van Dang C; Wasik MA
Leukemia; 2023 Dec; 37(12):2436-2447. PubMed ID: 37773266
[TBL] [Abstract][Full Text] [Related]
9. NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation.
Pawlicki JM; Cookmeyer DL; Maseda D; Everett JK; Wei F; Kong H; Zhang Q; Wang HY; Tobias JW; Walter DM; Zullo KM; Javaid S; Watkins A; Wasik MA; Bushman FD; Riley JL
Cancer Res; 2021 Jun; 81(12):3241-3254. PubMed ID: 33619116
[TBL] [Abstract][Full Text] [Related]
10. STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.
Prutsch N; He S; Berezovskaya A; Durbin AD; Dharia NV; Maher KA; Matthews JD; Hare L; Turner SD; Stegmaier K; Kenner L; Merkel O; Look AT; Abraham BJ; Zimmerman MW
Cell Rep Med; 2024 Mar; 5(3):101472. PubMed ID: 38508140
[TBL] [Abstract][Full Text] [Related]
11. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
Hapgood G; Ben-Neriah S; Mottok A; Lee DG; Robert K; Villa D; Sehn LH; Connors JM; Gascoyne RD; Feldman AL; Farinha P; Steidl C; Scott DW; Slack GW; Savage KJ
Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
[No Abstract] [Full Text] [Related]
12. Nucleophosmin: a versatile molecule associated with hematological malignancies.
Naoe T; Suzuki T; Kiyoi H; Urano T
Cancer Sci; 2006 Oct; 97(10):963-9. PubMed ID: 16984370
[TBL] [Abstract][Full Text] [Related]
13. A novel role for IL-22R1 as a driver of inflammation.
Savan R; McFarland AP; Reynolds DA; Feigenbaum L; Ramakrishnan K; Karwan M; Shirota H; Klinman DM; Dunleavy K; Pittaluga S; Anderson SK; Donnelly RP; Wilson WH; Young HA
Blood; 2011 Jan; 117(2):575-84. PubMed ID: 20971950
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic mutations of ALK in neuroblastoma.
Ogawa S; Takita J; Sanada M; Hayashi Y
Cancer Sci; 2011 Feb; 102(2):302-8. PubMed ID: 21205076
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma: a rare cause of ileal intussusception.
O'Hare EM; Thekkinedath A; Ngu L; McCullagh P
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36585041
[No Abstract] [Full Text] [Related]
16. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.
Knörr F; Schellekens KPJ; Schoot RA; Landman-Parker J; Teltschik HM; Förster J; Riquelme A; Huitema ADR; Van Eijkelenburg NKA; Beishuizen A; Zwaan CM; Woessmann W; Van der Lugt J
Haematologica; 2023 May; 108(5):1442-1446. PubMed ID: 36519329
[No Abstract] [Full Text] [Related]
17. Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms.
Ladanyi M
Am J Pathol; 2000 Aug; 157(2):341-5. PubMed ID: 10934137
[No Abstract] [Full Text] [Related]
18. Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors.
Lowe E; Mossé YP
Oncol Ther; 2024 Jun; 12(2):247-255. PubMed ID: 38676786
[TBL] [Abstract][Full Text] [Related]
19. Malignancy-Associated Secondary Hemophagocytic Lymphohistiocytosis Mimicking an Infection: A Case Report and Review of the Literature.
Gopalakrishnan M; Ramanathan A; Jayaraman D; Shanmugam SG; Xavier Scott J
Cureus; 2024 Mar; 16(3):e56738. PubMed ID: 38650799
[TBL] [Abstract][Full Text] [Related]
20. Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma.
Shang C; Lai J; Haque M; Chen W; Wang P; Lai R
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
